Eur. Respir. J. 58:2003969 (2021) Weckmann, M, Bahmer, T, Sand, J M, Rønnow, S R, Pech, M, Vermeulen, C, Faiz, A, Leeming, D J, Karsdal, M A, Lunding, L, Oliver, B G G, Wegmann, M, Ulrich-Merzenich, G, Juergens, U R, Duhn, J, Laumonnier, Y, Danov, O, Sewald, K, Zissler, U, Jonker, M, König, I, Hansen, G, von Mutius, E, Fuchs, O, Dittrich, A M, Schaub, B, Happle, C, Rabe, K F, van de Berge, M, Burgess, J K, Kopp, M V & the ALLIANCE Study Group as part of the German Centre for Lung Research (DZL) 2021, ' COL4A3 is degraded in allergic asthma and degradation predicts response to anti-IgE therapy ', European Respiratory Journal, vol. 58, no. 6, 2003969 . https://doi.org/10.1183/13993003.03969-2020 Weckmann, Markus; Bahmer, Thomas; Bülow Sand, Jannie Marie; Rank Rønnow, Sarah; Pech, Martin; Vermeulen, Cornelis; Faiz, Alen; Leeming, Diana Julie; Karsdal, Morten Asser; Lunding, Lars; Oliver, Brian George G; Wegmann, Michael; Ulrich-Merzenich, Gudrun; Juergens, Uwe R; Duhn, Jannis; Laumonnier, Yves; Danov, Olga; Sewald, Katherina; Zissler, Ulrich; Jonker, Marnix; ... (2021). COL4A3 is degraded in allergic asthma and degradation predicts response to anti-IgE therapy. European respiratory journal, 58(6) European Respiratory Society 10.1183/13993003.03969-2020 European Respiratory Journal, 58(6):2003969. EUROPEAN RESPIRATORY SOC JOURNALS LTD